Tekla Life Sciences Investors
Location
Massachusetts
Founded
2000-01-26
Website
Risk Signals
155 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Management Investment Offices, Open-End), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Stock Market Events (128)
Investment Strategies (101)
Equity Analysis & Ratings (42)
Acquisition Announcements (36)
Earnings Reports & Warnings (36)
Issuing Shares (34)
Stock Buyback (34)
Financial Reporting (18)
Corporate Deals (18)
Inter-Organizational Collaborations (17)
Regulatory Updates (17)
Asset Divestment (16)
Shareholders Feedback (15)
Offshore Tax Practices (14)
Capital Funding Requests (7)
Funding Announcements (6)
Business Growth Initiatives (5)
Corporate Governance Policies (4)
Workforce Reductions (2)
Corporate Restructuring (2)
Credit Rating Updates (2)
Illicit Financial Practices (2)
Initial Public Offering Launch (2)
New Product Release (2)
Access and Affordability Initiatives (2)
Legal and Regulatory Management (1)
Corporate Rebranding (1)
Competitive Market Dynamics (1)
Climate Change Effects (1)
Material Supply Trends (1)
Recent Articles about Tekla Life Sciences Investors
Live alerts from global media, monitored by Business Radar
2022-11-02 (reporter.am)
Victory Capital Management Inc. Raises Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
Victory Capital Management Inc. lifted its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) by 7.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
Read more